A peer-reviewed study published in Cell in March 2026 introduces “optovolution,” an in vivo directed-evolution system that ...

BBO-11818 is a selective, orally bioavailable non-covalent inhibitor that targets KRAS in both the ON and OFF states, has ...

BioLife Solutions has executed a successful turnaround by refocusing on core products and divesting non-core assets. Read ...

This manuscript describing the phenotypes associated with loss and gain of RVCL-S documents important findings that have practical implications. Although the data and methods are solid and support ...

Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarter2025 year-end cash and cash equivalents of $226.

Researchers reveal that salivary bacteria from gum disease alter gut metabolism, driving osteoclast activity and ...

Explore how proteomics enables personalized medicine by improving patient stratification, treatment response, and diagnostics ...

Explore the World ADC Conference highlights on antibody-drug conjugates and their impact on cancer therapy and clinical ...

Characterization of Italian resistance-breaking isolates of tomato spotted wilt virus reveals double resistance-breaking strains in tomato and pepper and new insights into the occurrence of the ...

Are you attending the ABRF Annual Meeting 2026? Here are the breakout sessions and workshops you won’t want to miss.

FIRST ANDES SILVER LTD. (TSXV: FAS) (OTC Pink: MSLVF) (FSE: 9TZ) ("First Andes" or the "Company") today reported Phase 1 soil ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from the fourth and final day of Symposium 2026. Day 4 featured updates from some of the most advanced and high-volume cytogenetics and ...